Further, new and emerging products for lipid emulsion and protein delivery are available.

Top takeaways on refining ASCVD risk assessment for individualized primary prevention, landmark cardiovascular outcomes trials, and appropriate interventions for patients at risk for ASCVD.

Insights into IFI incidence and diagnostic methods and the management of these infections.

Develop strategies for the co-management of atopic dermatitis (AD) and its associated comorbid conditions

Evaluate the clinical trials results of newly approved ocular hypotensive agents, including ROCK inhibitors and combination agents

Identify risk factors for significant morbidity and mortality that are associated with HF, particularly post hospitalization

Evidence-based information on adult GHD diagnosis, treatment, and barriers to adherence

Clinical data to support the personalization of care for patients with psoriatic arthritis (PsA).

Apply the results of clinical trials, expert recommendations, and consensus guidelines to develop treatment plans